Nanomedicine-based drug targeting for psoriasis: potentials and emerging trends in nanoscale pharmacotherapy

Bibliography

• Rahman M, Zaki Ahmad M, Kazmi I, et al. Insight into the biomarkers as the novel anti-psoriatic drug discovery tool: a contemporary viewpoint. Curr Drug Discov Technol 2012;9:48-62
   PubMedGoogle Scholar
• Rahman M, Alam K, Ahmad MZ, et al. Classical to current approach for treatment of psoriasis: a review. Endocr Metab Immune Disord Drug Targets 2012;12:287-302
   PubMedGoogle Scholar
• Katare OP, Raza K, Singh B, et al. Novel drug delivery systems in topical treatment of psoriasis: rigors and vigors. Indian J Dermatol Venereol Leprol 2010;76:612-21
   PubMed Web of Science ®Google Scholar
• Lynde CW, Poulin Y, Vender R, et al. Interleukin 17A: toward a new understanding of psoriasis pathogenesis. J Am Acad Dermatol 2014;71(1):141-50
   PubMed Web of Science ®Google Scholar
• Lowes MA, Suárez-Fariñas M, Krueger JG. Immunology of Psoriasis. Annu Rev Immunol 2014;32:227-55
   PubMed Web of Science ®Google Scholar
• Ryan C, Korman NJ, Gelfand JM, et al. Research gaps in psoriasis: opportunities for future studies. J Am Acad Dermatol 2014;70:146-67
   PubMed Web of Science ®Google Scholar
• Hao JQ. Targeting Interleukin-22 in Psoriasis. Inflammation 2014;37:94-9
   PubMed Web of Science ®Google Scholar
• Sobell JM, Leonardi CL. Therapeutic development in psoriasis. Semin Cutan Med Surg 2014;33(4):S69-72
   Google Scholar
• Van den Berg WB, McInnes IB. Th17 cells and IL-17 a – focus on immunopathogenesis and immunotherapeutics. Semin Arthritis Rheum 2013;43:158-70
   PubMed Web of Science ®Google Scholar
• Mudigonda P, Mudigonda T, Feneran AN, et al. Interleukin-23 and interleukin-17: importance in pathogenesis and therapy of psoriasis. Dermatol Online J 2012;18(10):1
   PubMedGoogle Scholar
• Yang J, Sundrud MS, Skepner J, Yamagata T. Targeting Th17 cells in autoimmune diseases. Trends Pharmacol Sci 2014;35(10):493-500
   PubMed Web of Science ®Google Scholar
• Rawat M, Singh D, Saraf S. Nanocarriers: promising vehicle for bioactive drugs. Biol Pharm Bull 2006;29:1790-8
   PubMed Web of Science ®Google Scholar
• Rahman M, Beg S, Ahmad MZ, et al. Omega-3 fatty acids as pharmacotherapeutics in psoriasis: current status and scope of nanomedicine in its effective delivery. Curr Drug Targets 2013;14:708-22
   PubMed Web of Science ®Google Scholar
• Saarinen-Savolainen P, Jarvinen T, Taipale H, Urtt A. Method for evaluating drug release from liposomes in sink conditions. Int J Pharm 1997;159:27-33
   Web of Science ®Google Scholar
• Lapteva M, Mondon K, Möller M, et al. Polymeric micelle nanocarriers for the cutaneous delivery of tacrolimus: a targeted approach for the treatment of psoriasis. Mol Pharm 2014;11(9):2989-3001
   PubMed Web of Science ®Google Scholar
• Fadda AM, Manconi M, Sinico C, et al. Penetration enhancer containing vesicles as carriers for dermal delivery of tretinoin. Int J Pharm 2011;412:37-46
   PubMedGoogle Scholar
• Ainbinder D, Paolino D, Fresta M, Touitou E. Drug delivery applications with ethosomes. J Biomed Nanotechnol 2010;6(5):558-68
   PubMed Web of Science ®Google Scholar
• Fireman S, Toledano O, Neimann K, et al. A look at emerging delivery systems for topical drug products. Dermatol Ther 2011;24(5):477-88
   PubMed Web of Science ®Google Scholar
• Umashankar MS, Sachdeva RK, Gulati M. Aquasomes: a promising carrier for peptides and protein delivery. Nanomed Nanotechnol Biol Med 2010;6:419-26
   PubMed Web of Science ®Google Scholar
• Vengala P, Dintakurthi S, Aslam S, et al. Aquasomes: a novel drug carrier system. Int Res J Pharm 2012;3:123-7
   Google Scholar
• Puglia C, Bonina F. Lipid nanoparticles as novel delivery systems for cosmetics and dermal pharmaceuticals. Expert Opin Drug Deliv 2012;9(4):429-41
   PubMed Web of Science ®Google Scholar
• Rawat M, Singh D, Saraf S, et al. Lipid carriers: a versatile delivery vehicle for proteins and peptides. Yakugaku Zasshi 2008;128:269-80
   PubMed Web of Science ®Google Scholar
• Martins S, Sarmento B, Ferreira DC, Souto EB. Lipid-based colloidal carriers for peptide and protein delivery liposomes versus lipid nanoparticles. Int J Nanomedicine 2007;2:595-607
   PubMed Web of Science ®Google Scholar
• Abdullah R, How CW, Abbasalipourkabir R. Characterization and stability of nanostruc tured lipid carriers as drug delivery system. Afr J Biotechnol 2011;10:1684-9
   Google Scholar
• Xia Q, Saupe A, Muller RH, et al. Nanostructured lipid carriers as novel carrier for sunscreen formulations. Int J Cosmet Sci 2007;29:473-82
   PubMed Web of Science ®Google Scholar
• Gupta S, Moulik SP. Biocompatible microemulsions and their prospective uses in drug delivery. J Pharm Sci 2008;97:22-43
   PubMed Web of Science ®Google Scholar
• Shaji J, Reddy MS. Microemulsion as drug delivery system. Pharma times 2004;36:17-24
   Google Scholar
• Alagusundaram M, Sudana M, Chetty C, et al. Microspheres as a novel drug delivery system- a review. Int J ChemTech Res 2009;1:526-34
   Google Scholar
• Chlapanidas T, Perteghella S, Leoni F, et al. TNF-α blocker effect of naringenin-loaded sericin microparticles that are potentially useful in the treatment of psoriasis. Int J Mol Sci 2014;15:13624-36
   PubMed Web of Science ®Google Scholar
• Madhav NVS, Saini A. Niosomes: a novel drug delivery system. Int J Res Pharm Chem 2011;1:498-511
   Google Scholar
• Manconi M, Sinico C, Valenti D, et al. Niosomes as carriers for tretinoin. I. Preparation and properties. Int J Pharm 2002;234:237-48
   PubMed Web of Science ®Google Scholar
• Kombath RV, Minumula SK, Sockalingam A, et al. Critical issues related to transfersomes - novel vesicular system. Acta Sci Pol Technol Aliment 2012;11:67-82
   Google Scholar
• Sharma J, Kalra S, Sharma A, Ran S. Colloidal drug carriers. Internet J Fam Pract 2010;9
   Google Scholar
• Torchilin VP. Structure and design of polymeric surfactant-based drug delivery systems. J Control Release 2001;73:137-72
   PubMed Web of Science ®Google Scholar
• Ulbrich W, Lamprecht A Targeted drug-delivery approaches by nanoparticulate carriers in the therapy of inflammatory diseases. J R Soc Interface 2010;7:S55-66
   Google Scholar
• Garg T. Current nanotechnological approaches for an effective delivery of bio-active drug molecules in the treatment of acne. Artif Cells Nanomed Biotechnol 2014;20:1-8
   Google Scholar
• Baboota S, Alam MS, Sharma S, et al. Nanocarrier-based hydrogel of betamethasone dipropionate and salicylic acid for treatment of psoriasis. Int J Pharm Investig 2011;3:139-47
   Google Scholar
• Zhang J, Smith E. Percutaneous permeation of betamethasone 17-valerate incorporated in lipid nanoparticles. J Pharm Sci 2011;100:896-903
   PubMed Web of Science ®Google Scholar
• Korting HC, Zienicke H, Schafer-Korting M, Braun-Falco O. Liposome encapsulation improves efficacy of betamethasone dipropionate in atopic eczema but not in psoriasis vulgaris. Eur J Clin Pharmacol 1990;39:349-51
   PubMed Web of Science ®Google Scholar
• Cevc G, Blume G. Hydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect, and reduced therapeutic dosage. Biochim Biophys Acta 2004;1663:61-73
   PubMed Web of Science ®Google Scholar
• Badıllı U, Sen T, Tarımcı N. Microparticulate based topical delivery system of clobetasol propionate. AAPS Pharm Sci Tech 2011;12:949-57
   PubMed Web of Science ®Google Scholar
• Baboota S, Rahman M, Kumar A, et al. Submicron size formulation of linseed oil containing ω-3 fatty acids for topical delivery. J Disp Sci Technol 2012;33:1259-66
   Web of Science ®Google Scholar
• Sharma S, Kumar A, Saini JK, et al. Nanoemulsion based hydrogels containing omega 3 fatty acids as a surrogate of betamethasone dipropionate for topical delivery. Adv Sci Lett 2012;6:221-31
   Google Scholar
• Kragballe K, Wildfang IL. Calcipotriol (MC 903), a novel vitamin D3 analogue, stimulates terminal differentiation and inhibits proliferation of cultured human keratinocytes. Arch Dermatol Res 1990;282:164-7
   PubMed Web of Science ®Google Scholar
• Lin YK, Huang ZR, Zhuo RZ, Fang JY. Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery. Int J Nanomedicine 2010;5:117-28
   PubMed Web of Science ®Google Scholar
• Prufer K, Jirikowski GF. Liposomal incorporation changes the effect of 1.25-dihydroxyvitamin D3 on the phospholipase C signal transduction pathway and the eicosanoid cascade on keratinocytes in vitro. Biochem Pharmacol 1996;51:247-52
   PubMed Web of Science ®Google Scholar
• Gehring W, Ghyczy M, Gloor M, et al. Enhancement of the penetration of dithranol and increase of effect of dithranol on the skin by liposomes. Arzneimittelforschung 1992;42:983-5
   PubMed Web of Science ®Google Scholar
• Saraswat A, Agarwal R, Kaur I, et al. Fabric- staining properties and washability of a novel liposomal dithranol formulation. J Dermatolog Treat 2002;13:119-22
   PubMed Web of Science ®Google Scholar
• Agarwal R, Saraswat A, Kaur I, et al. A novel liposomal formulation of dithranol for psoriasis: preliminary results. J Dermatol 2002;29:529-32
   PubMed Web of Science ®Google Scholar
• Agarwal R, Katare OP, Vyas SP. Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol. Int J Pharm 2001;228:43-52
   PubMed Web of Science ®Google Scholar
• Raza K, Negi P, Takyar S. Novel dithranol phospholipid microemulsion for topical application: development, characterization and percutaneous absorption studies. J Microencapsul 2011;28:190-9
   PubMed Web of Science ®Google Scholar
• Raza K, Katare OP, Setia A, et al. Improved therapeutic performance of dithranol against psoriasis employing systematically optimized nanoemulsomes. J Microencapsul 2013;3:225-36
   Google Scholar
• Sun J, Zhao Y, Hu J. Curcumin inhibits imiquimod-induced psoriasis-like inflammation by inhibiting IL-1beta and IL-6 production in mice. PLoS One 2013;8:67078
   PubMed Web of Science ®Google Scholar
• Nguyen TA, Friedman AJ. Curcumin: a novel treatment for skin-related disorders. J Drugs Dermatol 2013;12:1131-7
   PubMed Web of Science ®Google Scholar
• Liu CH, Chang FY. Development and characterization of eucalyptol microemulsions for topic delivery of curcumin. Chem Pharm Bull (Tokyo) 2011;59:172-8
   PubMed Web of Science ®Google Scholar
• Mulik R, Mahadik K, Paradkar A. Development of curcuminoids loaded poly (butyl) cyanoacrylate nanoparticles: physiocochemical characterization and stability study. Eur J Pharm Sci 2009;37:395-404
   PubMed Web of Science ®Google Scholar
• Patel R, Singh SK, Singh S, et al. Development and characterization of curcumin loaded transfersome for transdermal delivery. J Pharm Sci Res 2009;1:71-80
   Google Scholar
• Wittmann M, Helliwell PS. Phosphodiesterase 4 inhibition in the treatment of psoriasis, psoriatic arthritis and other chronic inflammatory diseases. Dermatol Ther 2013;3:1-15
   PubMedGoogle Scholar
• Klein M, Vaeth M, Scheel T, et al. Repression of cyclic adenosine monophosphate upregulation disarms and expands human regulatory T cells. J Immunol 2012;188:1091-7
   PubMed Web of Science ®Google Scholar
• Iancu L, Shneur A, Cohen H. Trials with xanthine derivatives in systemic treatment of psoriasis. Dermatologica 1979;159:55-61
   PubMedGoogle Scholar
• Touitou E, Shaco-Ezra N, Dayan N, et al. Dyphylline liposomes for delivery to the skin. J Pharm Sci 1992;81:131-4
   PubMed Web of Science ®Google Scholar
• Guo J, Ping Q, Sun G, Jiao C. Lecithin vesicular carriers for transdermal delivery of cyclosporine A. Int J Pharm 2000;194:201-17
   PubMed Web of Science ®Google Scholar
• Guo JX, Ping QN, Wu T. Transdermal delivery mechanisms of lecithin nanoparticles with cyclosporin A through mice skin. Yao Xue Xue Bao 2000;35:782-5
   PubMedGoogle Scholar
• Guo J, Wu T, Ping Q, et al. Solubilization and pharmacokinetic behaviors of sodium cholate/lecithin-mixed micelles containing cyclosporine A. Drug Deliv 2005;12:35-9
   PubMed Web of Science ®Google Scholar
• Boinpally RR, Zhou SL, Devraj G, et al. Iontophoresis of lecithin vesicles of cyclosporine A. Int J Pharm 2004;274:185-90
   PubMed Web of Science ®Google Scholar
• Liu H, Li S, Wang Y, et al. Effect of vehicles and enhancers on the topical delivery of cyclosporin A. Int J Pharm 2006;311:182-6
   PubMed Web of Science ®Google Scholar
• Ugazio E, Cavalli R, Gasco MR. Incorporation of cyclosporin A in solid lipid nanoparticles (SLN). Int J Pharm 2002;241:341-4
   PubMed Web of Science ®Google Scholar
• Verma DD, Fahr A. Synergistic penetration enhancement effect of ethanol and phospholipids on the topical delivery of cyclosporin A. J Control Release 2004;97:55-66
   PubMed Web of Science ®Google Scholar
• Katare OP, Kumar R, Singh B, et al. A multi-compartmental liposomal system for topical drug delivery. Patent Office J 2009;6210
   Google Scholar
• Remitz A, Reitamo S, Erkko P, et al. Tacrolimus ointment improves psoriasis in a microplaque assay. Br J Dermatol 1999;141:103-7
   PubMed Web of Science ®Google Scholar
• Pople PV, Singh KK. Development and evaluation of colloidal modified nanolipid carrier: application to topical delivery of tacrolimus. Eur J Pharm Biopharm 2011;79:82-94
   PubMed Web of Science ®Google Scholar
• Wohlrab J, Goebel A, Scherer D, et al. A topical tacrolimus microemulsion for plaque-type psoriasis therapy. Drug Develop Deliv 2012;12
   Google Scholar
• Thapa RK, Baskaran R, Madheswaran T, et al. Preparation, characterization, and release study of tacrolimus-loaded liquid crystalline nanoparticles. J Disp Sci Technol 2013;34:72-7
   Web of Science ®Google Scholar
• Wang R, Longnian Li, Wang B, et al. FK506-loaded solid lipid nanoparticles: preparation, characterization and in vitro transdermal drug delivery. Afr J Pharm Pharmacol 2012;6:904-13
   Web of Science ®Google Scholar
• Li G, Fan C, Li X, et al. Preparation and in vitro evaluation of tacrolimus-loaded ethosomes. Sci World J 2012;2012:874053
   Google Scholar
• Zhou ZL, Yang YX, Ding J, et al. Triptolide: structural modifications, structure– activity relationships, bioactivities, clinical development and mechanisms. Nat Prod Rep 2012;29:457-75
   PubMed Web of Science ®Google Scholar
• Mei Z, Chen H, Weng T, et al. Solid lipid nanoparticle and microemulsion for topical delivery of triptolide. Eur J Pharm Biopharm 2003;56:189-96
   PubMed Web of Science ®Google Scholar
• Chen L, Zhao X, Cai J, et al. Triptolide-loaded microemulsion-based hydrogels: physical properties and percutaneous permeability. Acta Pharm Sin B 2013;3:185-92
   Web of Science ®Google Scholar
• Ali MF, Salah M, Rafea M. Liposomal methotrexate hydrogel for treatment of localized psoriasis: preparation, characterization and laser targeting. Med Sci Monit 2008;12:I66-74
   Google Scholar
• Misra AK, Padhi BK, Chougule M. Methotrexate-loaded solid lipid nanoparticles for topical treatment of psoriasis: formulation and clinical implications. Drug Deliv Technol 2004;4:8
   Google Scholar
• Trotta M, Pattarino F, Gasco MR. Influence of counter ions on the skin permeation of methotrexate from water-oil microemulsions. Pharm Acta Helv 1996;71:135-40
   PubMedGoogle Scholar
• Trotta M, Peira E, Debernardi FM, et al. Elastic liposomes for skin delivery of dipotassium glycyrrhizinate. Int J Pharm 2002;241:319-27
   PubMed Web of Science ®Google Scholar
• Dubey V, Mishra D, Dutta T, et al. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. J Control Release 2007;123:148-54
   PubMed Web of Science ®Google Scholar
• Lakshmi PK, Devi GS, Bhaskaran S, et al. Niosomal methotrexate gel in the treatment of localized psoriasis: phase I and phase II studies. 2007;73:157-61
   Google Scholar
• Boyd AS, King LEJr. Tamoxifen-induced remission of psoriasis. J Am Acad Dermatol 1999;41:887-9
   PubMed Web of Science ®Google Scholar
• Bhatia A, Kumar R, Katare OP. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation. J Pharm Pharm Sci 2004;7:252-9
   PubMed Web of Science ®Google Scholar
• Bhatia A, Singh B, Wadhwa S, et al. Novel phospholipid-based topical formulations of tamoxifen: evaluation for antipsoriatic activity using mouse-tail model. Pharm Dev Technol 2014;19:160-3
   PubMed Web of Science ®Google Scholar
• Baroli B, López-Quintela MA, Delgado-Charro MB. Microemulsions for topical delivery of 8-methoxsalen. J Control Release 2000;69:209-18
   PubMed Web of Science ®Google Scholar
• Borowska K, Wolowiec S, Rubaj A, et al. Effect of polyamidone dendrimer G3 and G4 on skin permeation of 8-methoxypsoralene – in vivo study. Int J Pharm 2012;426:280-3
   PubMed Web of Science ®Google Scholar
• Gomes AJ, Lunardi LO, Caetano FH, et al. Biodegradable nanoparticles containing benzopsoralen: an attractive strategy for modifying vascular function in pathological skin disorders. J Appl Polym Sci 2011;121:1348-54
   Web of Science ®Google Scholar
• Fang JY, Fang CL, Liu CH, Su YH. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Eur J Pharm Biopharm 2008;70:633-40
   PubMed Web of Science ®Google Scholar
• Ali J, Akhtar N, Sultana Y, et al. Antipsoriatic microemulsion gel formulations for topical drug delivery of babchi oil (Psoralea corylifolia). Methods Find Exp Clin Pharmacol 2008;30:277-85
   PubMed Web of Science ®Google Scholar
• Marwaha TK. Formulation design and evaluation of herbal antipsoriatic emulgel. J Pharm Sci Innov 2013;2:30-42
   Google Scholar
• Alam MS, Ali MS, Alam N, et al. Design and characterization of nanostructure topical gel of betamethasone dipropionate for psoriasis. J Appl Pharm Sci 2012;2:148-58
   Google Scholar
• Ibbotson SH. Topical 5-aminolaevulinic acid photodynamic therapy for the treatment of skin conditions other than non- melanoma skin cancer. Br J Dermatol 2002;146:178-88
   PubMed Web of Science ®Google Scholar
• Fang YP, Huang YB, Wu PC, Tsai YH. Topical delivery of 5-aminolevulinic acid-encapsulated ethosomes in a hyperproliferative skin animal model using the CLSM technique to evaluate the penetration behavior. Eur J Pharm Biopharm 2009;73:391-8
   PubMed Web of Science ®Google Scholar
• Dragicevic-Curic N, Scheglmann D, Albrecht V, et al. Development of liposomes containing ethanol for skin delivery of temoporfin: characterization and in vitro penetration studies. Colloids Surf B Biointerfaces 2009;74:114-22
   PubMed Web of Science ®Google Scholar
• Dragicevic-Curic N, Scheglmann D, Albrecht V, et al. Temoporfin-loaded invasomes: development, characterization and in vitro skin penetration studies. J Control Release 2008;127:59-69
   PubMed Web of Science ®Google Scholar
• Dragicevic-Curic N, Gräfe S, Gitter B, et al. Surface charged temoporfin-loaded flexible vesicles: in vitro skin penetration studies and stability. Int J Pharm 2010;384:100-8
   PubMed Web of Science ®Google Scholar
• Dragicevic-Curic N, Winter S, Krajisnik D, et al. Stability evaluation of temoporfin-loaded liposomal gels for topical application. J Liposome Res 2010;20:38-48
   PubMed Web of Science ®Google Scholar
• Bhatia A, Raza K, Singh B, Katare OP. Phospholipid-based formulation with improved attributes of coal tar. J Cosmet Dermatol 2009;8:282-8
   PubMed Web of Science ®Google Scholar
• Agrawal Y, Petkar KC, Sawant KK. Development, evaluation and clinical studies of Acitretin loaded nanostructured lipid carriers for topical treatment of psoriasis. Int J Pharm 2010;401:93-102
   PubMed Web of Science ®Google Scholar
• Nasrollahi SA, Abbasian AR, Farboud ES. In vitro comparison of simple tretinoin-cream and cream loaded with tretinoin-SLN. J Pharm Technol Drug Res 2013;2:13
   Google Scholar
• Dinarvand R, Rahmani E, Farbod E. Gelatin microspheres for the controlled release of all-trans-retinoic acid topical formulation and drug delivery evaluation. Iranian J Pharm Res 2003;2:47-50
   Google Scholar
• Ourique AF, Pohlmann AR, Guterres SS, et al. Tretinoin-loaded nanocapsules: preparation, physicochemical characterization, and photostability study. Int J Pharm 2008;352:1-4
   PubMed Web of Science ®Google Scholar
• Raza K, Singh B, Lohan S, et al. Nano lipoidal carriers of tretinoin with enhanced percutaneous absorption, photostablity, biocompatibility and antipsoriatic activity. Int J Pharm 2013;456:65-72
   PubMed Web of Science ®Google Scholar
• Clares B, Calpena AC, Parra A, et al. Nanoemulsions (NEs), liposomes (LPs) and solid lipid nanoparticles (SLNs) for retinyl palmitate: effect on skin permeation. Int J Pharm 2014;473:591-8
   PubMed Web of Science ®Google Scholar
• Bernstein JE, Parish LC, Rapaport M. Effects of topically applied capsaicin on moderate and severe psoriasis vulgaris. J Am Acad Dermatol 1986;15:504-7
   PubMed Web of Science ®Google Scholar
• Agrawal U, Gupta M, Vyas SP. Capsaicin delivery into the skin with lipidic nanoparticles for the treatment of psoriasis. Artif Cells Nanomed Biotechnol 2013;1-7. 10.3109/21691401.2013.832683
   Google Scholar
• Raza K, Singh B, Mahajan A, et al. Design and evaluation of flexible membrane vesicles (FMVs) for enhanced topical delivery of capsaicin. J Drug Target 2011;19:293-302
   PubMed Web of Science ®Google Scholar
• Bishtaba K, Wagnerb KH, Andrew C. Bulmer Curcumin, resveratrol and flavonoids as anti-inflammatory, cyto- and DNA-protective dietary compounds. Toxicology 2010;278:88-100
   PubMed Web of Science ®Google Scholar
• Scognamiglio I, De Stefano D, Campani V, et al. Nanocarriers for topical administration of resveratrol: a comparative study. Int J Pharm 2013;440:179-87
   PubMed Web of Science ®Google Scholar
• Pando D, Caddeo C, Manconi M, et al. Nanodesign of olein vesicles for the topical delivery of the antioxidant resveratrol. J Pharm Pharmacol 2013;65:1158-67
   PubMed Web of Science ®Google Scholar
• Zhang Z, Tsai PC, Ramezanli T, et al. Polymeric nanoparticles-based topical delivery systems for the treatment of dermatological diseases. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2013;5:205-18
   PubMed Web of Science ®Google Scholar
• Kilfoyle BE, Sheihet L, Zhang Z, et al. Development of paclitaxel-TyroSpheres for topical skin treatment. J Control Release 2012;163:18-24
   PubMed Web of Science ®Google Scholar